Skip to main content

Optimal Control of Methadone Treatment in Preventing Blood-Borne Disease

  • Conference paper
Book cover Operations Research Proceedings 2002

Part of the book series: Operations Research Proceedings 2002 ((ORP,volume 2002))

  • 435 Accesses

Abstract

In this paper an optimal control model describing the influence of methadone maintenance treatment (MMT) on the spread of blood-borne diseases like Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) among injection drug users is analyzed. The aim of the model is to find the optimal policy to minimize the discounted stream of the overall costs arising from MMT and the social costs caused by new infections from HIV and HCV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Alter and L. Moyer. The importance of preventing Hepatitis C Virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Sl):6–10, 1998.

    Article  Google Scholar 

  2. CDC. Recommendations for prevention and control of Hepatitis C Virus (HCV) infection and HCV-related chronic disease. Technical Report 47 (RR 19), MMWR,1998.

    Google Scholar 

  3. T. D’Aunno, T. Vaughn, and P. McElroy. An institutional analysis of HIV prevention efforts by the nations outpatient drug abuse treatment units. Journal of Health and Social Behaviour, 40(2):175–92, 1999.

    Article  Google Scholar 

  4. G.Feichtinger and R.F. Hartl.Optimale Kontrolle ökonomischer Prozesse.Walter de Gruyter,Berlin,1986

    Book  Google Scholar 

  5. G. Feichtinger and G. Tragler. Skiba thresholds in optimal control of illicit drug use. In G. Zaccour, editor, Optimal Control and Differential Games. Kluwer Academic Publisher, Boston, 2002.

    Google Scholar 

  6. D.R. Holtgrave and S.D. Pinkerton. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology,16(1):54–62, 1997.

    Google Scholar 

  7. M. No Time to Lose: Making the Most of HIV Prevention. National Academy Press, Washington, DC, 2000.

    Google Scholar 

  8. H.A. Pollack. The cost-effectiveness of methadone in preventing blood-borne disease: A comparison of HIV and Hepatitis C. Working Paper, 200s0.

    Google Scholar 

  9. H.A. Pollack. Controlling infectious diseases among injection drug users: Learning (the right) lessons from HIV. Working Paper, 2001.

    Google Scholar 

  10. J.B. Wong. Cost-effectiveness of treatments for chronic Hepatitis C. American Journal of Medicine, 107(6B):74–78, 1999.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Almeder, J. (2003). Optimal Control of Methadone Treatment in Preventing Blood-Borne Disease. In: Leopold-Wildburger, U., Rendl, F., Wäscher, G. (eds) Operations Research Proceedings 2002. Operations Research Proceedings 2002, vol 2002. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55537-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55537-4_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00387-8

  • Online ISBN: 978-3-642-55537-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics